Kelley Robert J. 4
4 · Talis Biomedical Corp · Filed Apr 11, 2023
Insider Transaction Report
Form 4
Kelley Robert J.
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2023-04-07+500,000→ 500,000 totalExercise: $0.49Exp: 2033-04-07→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date of March 1, 2023 and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.